Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
LILA
|
Balan Nair
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 9,956 Added 1.68% |
$71,086
$7.14 p/Share
|
Oct 07
2020 |
|
LILA
|
Christopher J Noyes
SVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 1,274 Added 0.76% |
$9,096
$7.14 p/Share
|
Oct 07
2020 |
|
LILA
|
Daniel E. Sanchez
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 68 Added 2.48% |
$486
$7.14 p/Share
|
Oct 07
2020 |
|
TEX
|
Amy George
Senior V.P. Human Resources |
BUY
Open market or private purchase
|
Direct | 164 Added 0.13% |
$4,008
$24.44 p/Share
|
Oct 07
2020 |
|
TEX
|
John D Sheehan |
BUY
Open market or private purchase
|
Direct | 341 Added 0.12% |
$8,354
$24.5 p/Share
|
Oct 07
2020 |
|
HLIO
|
Marc Bertoneche
Director |
BUY
Grant, award, or other acquisition
|
Direct | 600 Added 2.77% |
$23,472
$39.12 p/Share
|
Oct 07
2020 |
|
HLIO
|
Philippe Lemaitre |
BUY
Grant, award, or other acquisition
|
Direct | 1,100 Added 2.16% |
$43,032
$39.12 p/Share
|
Oct 07
2020 |
|
HLIO
|
Alexander Schuetz |
SELL
Other acquisition or disposition
|
Direct | 300 Reduced 4.47% |
$11,736
$39.12 p/Share
|
Oct 07
2020 |
|
HLIO
|
Alexander Schuetz |
BUY
Grant, award, or other acquisition
|
Direct | 1,000 Added 12.96% |
$39,120
$39.12 p/Share
|
Oct 07
2020 |
|
HLIO
|
Douglas Britt |
BUY
Grant, award, or other acquisition
|
Direct | 800 Added 6.2% |
$31,296
$39.12 p/Share
|
Oct 07
2020 |
|
HLIO
|
Kennon Guglielmo
Director |
BUY
Grant, award, or other acquisition
|
Direct | 600 Added 12.5% |
$23,472
$39.12 p/Share
|
Oct 07
2020 |
|
HLIO
|
Laura D Brown |
BUY
Grant, award, or other acquisition
|
Direct | 600 Added 33.33% |
$23,472
$39.12 p/Share
|
Oct 07
2020 |
|
HLIO
|
Cary Chenanda |
BUY
Grant, award, or other acquisition
|
Direct | 600 Added 33.33% |
$23,472
$39.12 p/Share
|
Oct 07
2020 |
|
HLIO
|
Gregory C Yadley
Director |
BUY
Grant, award, or other acquisition
|
Direct | 600 Added 7.13% |
$23,472
$39.12 p/Share
|
Oct 07
2020 |
|
LBRT
|
Riverstone/Carlyle Energy Partners Iv, L.P.
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 4,016,965 Added 37.82% |
-
|
Oct 07
2020 |
|
LBRT
|
Riverstone/Carlyle Energy Partners Iv, L.P.
Director |
SELL
Open market or private sale
|
Indirect | 5,750,000 Reduced 38.86% |
$49,507,498
$8.61 p/Share
|
Oct 07
2020 |
|
LBRT
|
Riverstone/Carlyle Energy Partners Iv, L.P.
Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect | 4,016,965 Reduced 18.94% |
-
|
Oct 07
2020 |
|
VRNT
|
Peter Fante
Chief Administrative Officer |
SELL
Open market or private sale
|
Direct | 3,344 Reduced 6.84% |
$172,015
$51.44 p/Share
|
Oct 07
2020 |
|
SPT
|
Joseph Del Preto
CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 4.07% |
$173,800
$43.45 p/Share
|
Oct 07
2020 |
|
VIR
|
Phillip Pang
EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 12,500 Reduced 29.57% |
$521,750
$41.74 p/Share
|
Oct 07
2020 |
|
VIR
|
Phillip Pang
EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 12,500 Added 22.82% |
$19,375
$1.55 p/Share
|
Oct 07
2020 |
|
SAM
|
C James Koch
Chairman |
SELL
Open market or private sale
|
Indirect | 2,660 Reduced 4.68% |
$2,448,530
$920.5 p/Share
|
Oct 07
2020 |
|
SAM
|
Cynthia A Fisher |
SELL
Open market or private sale
|
Indirect | 2,660 Reduced 4.68% |
$2,448,530
$920.5 p/Share
|
Oct 07
2020 |
|
W
|
James R. Miller
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 500 Reduced 2.19% |
$153,475
$306.95 p/Share
|
Oct 07
2020 |
|
AXON
|
Matthew R Mcbrady
Director |
SELL
Open market or private sale
|
Direct | 485 Reduced 5.45% |
$46,313
$95.49 p/Share
|
Oct 07
2020 |
|
ZG
|
David A. Beitel
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 9,150 Reduced 14.3% |
$981,063
$107.22 p/Share
|
Oct 07
2020 |
|
ZG
|
David A. Beitel
Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 9,150 Added 12.51% |
$238,449
$26.06 p/Share
|
Oct 07
2020 |
|
DOCU
|
Scott V. Olrich
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 5,800 Reduced 2.18% |
$1,303,202
$224.69 p/Share
|
Oct 07
2020 |
|
LDOS
|
Miriam E John
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 393 Added 0.54% |
$34,981
$89.01 p/Share
|
Oct 07
2020 |
|
BMRN
|
Elaine J Heron
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 15,000 Added 18.3% |
$397,350
$26.49 p/Share
|
Oct 07
2020 |
|
ILMN
|
Jay T Flatley
Director |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.48% |
$324,010
$324.01 p/Share
|
Oct 07
2020 |
|
ILMN
|
Susan H Tousi
SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.22% |
$32,500
$325.0 p/Share
|
Oct 07
2020 |
|
BF-B
|
Ralph E De Chabert
SVP, Chief Diversity Officer |
SELL
Open market or private sale
|
Direct | 695 Reduced 23.92% |
$48,428
$69.68 p/Share
|
Oct 07
2020 |
|
HSY
|
Pamela M Arway
Director |
SELL
Open market or private sale
|
Direct | 256 Reduced 1.57% |
$36,357
$142.02 p/Share
|
Oct 07
2020 |
|
MCHX
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,000,000 Added 22.52% |
$10,750,000
$2.15 p/Share
|
Oct 07
2020 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.5% |
$898
$1.33 p/Share
|
Oct 07
2020 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 14 Added 0.01% |
$6,622
$472.98 p/Share
|
Oct 07
2020 |
|
RAD
|
James J Peters
Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 5,858 Reduced 4.96% |
$60,396
$10.31 p/Share
|
Oct 07
2020 |
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 0.05% |
$3,859,050
$257.27 p/Share
|
Oct 07
2020 |
|
CRM
|
Srinivas Tallapragada
Chief Eng/Cust Success Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 10.25% |
$1,274,750
$254.95 p/Share
|
Oct 07
2020 |
|
CRM
|
Srinivas Tallapragada
Chief Eng/Cust Success Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 5,000 Added 9.29% |
$404,950
$80.99 p/Share
|
Oct 07
2020 |
|
TYME
|
Steve Hoffman
Director |
SELL
Open market or private sale
|
Direct | 31,250 Reduced 0.12% |
$30,938
$0.99 p/Share
|
Oct 07
2020 |
|
FREQ
|
Christopher R. Loose
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 8,000 Reduced 7.16% |
$160,000
$20.0 p/Share
|
Oct 07
2020 |
|
BDTX
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Direct | 24,590 Reduced 0.43% |
$825,240
$33.56 p/Share
|
Oct 07
2020 |
|
BDTX
|
Versant Venture Capital Vi, L.P. |
BUY
Other acquisition or disposition
|
Indirect | 5,312 Added 48.21% |
-
|
Oct 07
2020 |
|
BDTX
|
Versant Venture Capital Vi, L.P. |
SELL
Open market or private sale
|
Indirect | 3,246 Reduced 0.31% |
$108,936
$33.56 p/Share
|
Oct 07
2020 |
|
BDTX
|
Versant Venture Capital Vi, L.P. |
SELL
Other acquisition or disposition
|
Indirect | 294,920 Reduced 54.15% |
-
|
Oct 07
2020 |
|
BDTX
|
Bradley J Ph D Bolzon
Director |
SELL
Open market or private sale
|
Indirect | 27,836 Reduced 0.37% |
$934,176
$33.56 p/Share
|
Oct 07
2020 |
|
BDTX
|
Bradley J Ph D Bolzon
Director |
BUY
Other acquisition or disposition
|
Indirect | 5,312 Added 48.21% |
-
|
Oct 07
2020 |
|
BDTX
|
Bradley J Ph D Bolzon
Director |
SELL
Other acquisition or disposition
|
Indirect | 294,920 Reduced 54.15% |
-
|
Oct 07
2020 |